Lexaria Bioscience Corp.
Extracted from this filing and checked against the source text.
Lexaria Bioscience Corp. shareholders approved To Appoint Malone Bailey LLP as Auditors at the 2024-04-23 meeting.
To Appoint Malone Bailey LLP as Auditors 6,566,179 59,519 39,529 0 99 %View on SEC.gov
Lexaria Bioscience Corp. shareholders approved Election of Directors at the 2024-04-23 meeting.
To Elect Chris Bunka as a director 4,188,641 43,840 N/A 2,432,746 99 % To Elect John Docherty as a director 4,189,577 42,904 N/A 2,432,746 99 % To Elect Nicholas Baxter as a director 4,161,194 71,287 N/A 2,432,746 98 % To Elect Ted McKechnie as a director 3,735,858 496,623 N/A 2,432,746 88 % To Elect Albert Reese Jr. as a director 3,603,029 629,452 N/A 2,432,746 85 % To Elect Dr. Catherine Turkel as a director 4,181,783 50,698 N/A 2,432,746 99 %View on SEC.gov
Lexaria Bioscience Corp. shareholders approved To Ratify the lawful actions of the directors for the past year at the 2024-04-23 meeting.
To Ratify the lawful actions of the directors for the past year 4,110,965 67,011 54,505 2,432,746 97 %View on SEC.gov
425 shareholder votes filed in the last 30 days. Browse all shareholder votes →
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.